This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Nagar S, Blanchard RL. Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT)1A family members and its role in patient response to irinotecan. Drug Metab Rev. 2006; 38(3): 393-409.NagarSBlanchardRLPharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT)1A family members and its role in patient response to irinotecanDrug Metab Rev2006383393–40910.1080/03602530600739835Search in Google Scholar
Barbarino JM, Haidar CE, Klein TE, Altman RB. PharmGKB summary: Very important information for UGT1A1. Pharmacogenet Genomics. 2014; 24(3): 177-183.BarbarinoJMHaidarCEKleinTEAltmanRBPharmGKB summary: Very important information for UGT1A1Pharmacogenet Genomics2014243177–18310.1097/FPC.0000000000000024Search in Google Scholar
Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, et al. Thirteen UDP-glucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics. 2001; 11(4): 357-368.GongQHChoJWHuangTPotterCGholamiNBasuNKThirteen UDP-glucuronosyltransferase genes are encoded at the human UGT1 gene complex locusPharmacogenetics2001114357–36810.1097/00008571-200106000-00011Search in Google Scholar
Strassburg CP, Kneip S, Topp J, Obermayer-Straub P, Barut A, Tukey RH, et al. Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine. J Biol Chem. 2000; 275(46): 36164-36171.StrassburgCPKneipSToppJObermayer-StraubPBarutATukeyRHPolymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestineJ Biol Chem20002754636164–3617110.1074/jbc.M002180200Search in Google Scholar
Strassburg CP, Nguyen N, Manns MP, Tukey RH. Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. Mol Pharmacol. 1998; 54(4): 647-654.StrassburgCPNguyenNMannsMPTukeyRHPolymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epitheliumMol Pharmacol1998544647–654Search in Google Scholar
Wisnumurti D, Sribudiani Y, Porsch RM, Maskoen AM, Abdulhamied LI, Rahayuningsih SE, et al. UGT1A1 genetic variations and haplotype associated with neonatal hyperbilirubinemia in Indonesian population. Biomed Res Int. 2018; 2018: 9425843. doi: 10.1155/2018/9425843.WisnumurtiDSribudianiYPorschRMMaskoenAMAbdulhamiedLIRahayuningsihSEUGT1A1 genetic variations and haplotype associated with neonatal hyperbilirubinemia in Indonesian populationBiomed Res Int201820189425843doi: 10.1155/2018/942584310.1155/2018/9425843Search in Google Scholar
Marques SC, Ikediobi ON. The clinical application of UGT1A1 pharmacogenetic testing: Gene-environment interactions. Hum Genomics. 2010; 4(4): 238-249.MarquesSCIkediobiONThe clinical application of UGT1A1 pharmacogenetic testing: Gene-environment interactionsHum Genomics201044238–24910.1186/1479-7364-4-4-238Search in Google Scholar
Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndrome. N Engl J Med. 1995; 333(18): 1171-1175.BosmaPJChowdhuryJRBakkerCGantlaSdeBoer AOostraBAThe genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndromeN Engl J Med1995333181171–117510.1056/NEJM199511023331802Search in Google Scholar
Aono S, Adachi Y, Uyama E, Yamada Y, Keino H, Nanno T, et al. Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert’s syndrome. Lancet. 1995; 345(8955): 958-959.AonoSAdachiYUyamaEYamadaYKeinoHNannoTAnalysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert’s syndromeLancet19953458955958–95910.1016/S0140-6736(95)90702-5Search in Google Scholar
Bosma P, Chowdhury JR, Jansen PH. Genetic inheritance of Gilbert’s syndrome. Lancet. 1995; 346(8970): 314-315.BosmaPChowdhuryJRJansenPHGenetic inheritance of Gilbert’s syndromeLancet19953468970314–31510.1016/S0140-6736(95)92203-2Search in Google Scholar
Radlović N. Hereditary hyperbilirubinemias. Srp Arh Celok Lek. 2014; 142(3-4): 257-260.RadlovićNHereditary hyperbilirubinemiasSrp Arh Celok Lek20141423-4257–26010.2298/SARH1404257R24839786Search in Google Scholar
Radu P, Atsom J. Gilbert’s syndrome-clinical and pharmacological implications. Isr Med Assoc J. 2001; 3(8): 593-598.RaduPAtsomJGilbert’s syndrome-clinical and pharmacological implicationsIsr Med Assoc J200138593–598Search in Google Scholar
Radlović N, Leković Z, Mladenović M, Ristić D, Radlović V, Lekić V, et al. Gilbert’s syndrome in children – Our experience. Srp Arh Celok Lek. 2007; 135(5-6): 317-320.RadlovićNLekovićZMladenovićMRistićDRadlovićVLekićVGilbert’s syndrome in children – Our experienceSrp Arh Celok Lek20071355-6317–32010.2298/SARH0706317RSearch in Google Scholar
Radlović N, Ristić D, Brdar R, Janić N, Leković Z, Janić D, et al. Association of hereditary elliptocytosis and Gilbert’s syndrome as the cause of biliary calculosis: Case report. Srp Arh Celok Lek. 2011; 139(5-6): 386-389.RadlovićNRistićDBrdarRJanićNLekovićZJanićDAssociation of hereditary elliptocytosis and Gilbert’s syndrome as the cause of biliary calculosis: Case reportSrp Arh Celok Lek20111395-6386–38910.2298/SARH1106386RSearch in Google Scholar
Memon N, Weinberger BI, Hegyi T, Aleksunes LM. Inherited disorders of bilirubin clearance. Pediatr Res. 2016; 79(3): 378-386.MemonNWeinbergerBIHegyiTAleksunesLMInherited disorders of bilirubin clearancePediatr Res2016793378–38610.1038/pr.2015.247Search in Google Scholar
Pharmacogenomics Knowledge Base (https://www.pharmgkb.org) [accessed: April 10 2018]Pharmacogenomics Knowledge Base(https://www.pharmgkb.org)[accessed: April 10 2018]Search in Google Scholar
Ha VH, Jupp J, Tsang RY. Oncology drug dosing in Gilbert Syndrome associated with UGT1A1: A summary of the literature. Pharmacotherapy. 2017; 37(8): 956-972.HaVHJuppJTsangRYOncology drug dosing in Gilbert Syndrome associated with UGT1A1: A summary of the literaturePharmacotherapy2017378956–97210.1002/phar.1946Search in Google Scholar
de Morais SM, Uetrecht JP, Wells PG. Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert’s syndrome. Gastroenterology. 1992; 102(2): 577-586.deMorais SMUetrechtJPWellsPGDecreased glucuronidation and increased bioactivation of acetaminophen in Gilbert’s syndromeGastroenterology19921022577–58610.1016/0016-5085(92)90106-9Search in Google Scholar
Berg AO, Armstrong K, Botkin J, Calonge N, Haddow J, Kaye C, et al. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? Genet Med. 2009; 11(1): 15-20.BergAOArmstrongKBotkinJCalongeNHaddowJKayeCEvaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group Recommendations from the EGAPP Working Group: Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?Genet Med200911115–2010.1097/GIM.0b013e31818efd9d274361019125128Search in Google Scholar
Zucker SD, Qin X, Rouster SD, Yu F, Green RM, Keshavan P, et al. Mechanism of indinavir-induced hyper-bilirubinemia. Proc Natl Acad Sci USA. 2001; 98(22): 12671-12676.ZuckerSDQinXRousterSDYuFGreenRMKeshavanPMechanism of indinavir-induced hyper-bilirubinemiaProc Natl Acad Sci USA2001982212671–1267610.1073/pnas.2311406986011211606755Search in Google Scholar
Radojkovic D, Kusic J. Silver staining of denaturing gradient gel electrophoresis gels. Clin Chem. 2000; 46(6 Pt 1): 883-884.RadojkovicDKusicJSilver staining of denaturing gradient gel electrophoresis gelsClin Chem2000466 Pt 1883–88410.1093/clinchem/46.6.883Search in Google Scholar
Ribrag V, Koscielny S, Casasnovas O, Cazeneuve C, Brice P, Morschhauser F, et al. Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis. Blood. 2009; 113(14): 3307-3313.RibragVKoscielnySCasasnovasOCazeneuveCBricePMorschhauserFPharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosisBlood2009113143307–331310.1182/blood-2008-03-14887418768784Search in Google Scholar
Karan-Djurasevic T, Palibrk V, Kostic T, Spasovski V, Nikcevic G, Srzentic S, et al. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk. 2012; 12(4): 252-260.Karan-DjurasevicTPalibrkVKosticTSpasovskiVNikcevicGSrzenticSMutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemiaClin Lymphoma Myeloma Leuk2012124252–26010.1016/j.clml.2012.03.00522560084Search in Google Scholar
Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet. 2005; 76(5): 887-893.WiggintonJECutlerDJAbecasisGRA note on exact tests of Hardy-Weinberg equilibriumAm J Hum Genet2005765887–89310.1086/429864Search in Google Scholar
Radoi VE, Ursu RI, Poenaru E, Arsene C, Bohiltea CL, Bohiltea R. Frequency of the UGT1A1*28 polymorphism in a Romanian cohort of Gilbert Syndrome individuals. J Gastrointestin Liver Dis. 2017; 26(1): 25-28.RadoiVEUrsuRIPoenaruEArseneCBohilteaCLBohilteaRFrequency of the UGT1A1*28 polymorphism in a Romanian cohort of Gilbert Syndrome individualsJ Gastrointestin Liver Dis201726125–2810.15403/jgld.2014.1121.261.ugtSearch in Google Scholar
Torres AK, Escartín N, Monzó C, Guzmán C, Ferrer I, González-Munoz C, et al. Genetic susceptibility to Gilbert’s syndrome in a Valencian population; efficacy of the fasting test. Rev Clin Esp. 2017; 217(1): 1-6.TorresAKEscartínNMonzóCGuzmánCFerrerIGonzález-MunozCGenetic susceptibility to Gilbert’s syndrome in a Valencian population; efficacy of the fasting testRev Clin Esp201721711–610.1016/j.rceng.2016.10.004Search in Google Scholar
Viennas E, Komianou A, Mizzi C, Stojiljkovic M, Mitropoulou C, Muilu J, et al. Expanded national database collection and data coverage in the FINDbase worldwide database for clinically relevant genomic variation allele frequencies. Nucleic Acids Res. 2017; 45(D1): D846-D853.ViennasEKomianouAMizziCStojiljkovicMMitropoulouCMuiluJExpanded national database collection and data coverage in the FINDbase worldwide database for clinically relevant genomic variation allele frequenciesNucleic Acids Res201745D1D846–D85310.1093/nar/gkw949Search in Google Scholar
Beutler E, Gelbart T, Demina A. Racial variability in the UDP glucuronosyltransferase 1 (UGT1A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA. 1998; 95(14): 8170-8174.BeutlerEGelbartTDeminaARacial variability in the UDP glucuronosyltransferase 1 (UGT1A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism?Proc Natl Acad Sci USA199895148170–817410.1073/pnas.95.14.8170Search in Google Scholar
Premawardhena A, Fisher CA, Liu YT, Verma IC, de Silva S, Arambepola M, et al. The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): Hematologic and evolutionary implications. Blood Cells Mol Dis. 2003; 31(1): 98-101.PremawardhenaAFisherCALiuYTVermaICdeSilva SArambepolaMThe global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): Hematologic and evolutionary implicationsBlood Cells Mol Dis200331198–10110.1016/S1079-9796(03)00071-8Search in Google Scholar
Bajro MH, Josifovski T, Panovski M, Jankulovski N, Nestorovska AK, Matevska N, et al. Promoter length polymorphism in UGT1A1 and the risk of sporadic colorectal cancer. Cancer Genet. 2012; 205(4): 163-167.BajroMHJosifovskiTPanovskiMJankulovskiNNestorovskaAKMatevskaNPromoter length polymorphism in UGT1A1 and the risk of sporadic colorectal cancerCancer Genet20122054163–16710.1016/j.cancergen.2012.01.01522559977Search in Google Scholar
Kapedanovska Nestorovska A, Jakovski K, Naumovska Z, Hiljadnikova Bajro M, Sterjev Z, Eftimov A, et al. Distribution of the most common genetic variants associated with a variable drug response in the population of the Republic of Macedonia. Balkan J Med Genet. 2015; 17(2): 5-14.KapedanovskaNestorovska AJakovskiKNaumovskaZHiljadnikovaBajro MSterjevZEftimovADistribution of the most common genetic variants associated with a variable drug response in the population of the Republic of MacedoniaBalkan J Med Genet20151725–1410.2478/bjmg-2014-0069441343725937793Search in Google Scholar
Marinković N, Pasalić D, Grsković B, Ferencak G, Honović L, Rukavina AS. Genotype frequencies of UDP-glucuronosyltransferase 1A1 promoter gene polymorphism in the population of healthy Croatian pre-scholars. Coll Antropol. 2008; 32(3): 725-729.MarinkovićNPasalićDGrskovićBFerencakGHonovićLRukavinaASGenotype frequencies of UDP-glucuronosyltransferase 1A1 promoter gene polymorphism in the population of healthy Croatian pre-scholarsColl Antropol2008323725–729Search in Google Scholar
Mlakar SJ, Ostanek B. Development of a new DHPLC assay for genotyping UGT1A (TA)n polymorphism associated with Gilbert’s syndrome. Biochem Med (Zagreb). 2011; 21(2): 167-173.MlakarSJOstanekBDevelopment of a new DHPLC assay for genotyping UGT1A (TA)n polymorphism associated with Gilbert’s syndromeBiochem Med (Zagreb)2011212167–17310.11613/BM.2011.026Search in Google Scholar
Ostanek B, Furlan D, Mavec T, Lukac-Bajalo J. UGT1A1(TA)n promoter polymorphism — A new case of a (TA)8 allele in Caucasians. Blood Cells Mol Dis. 2007; 38(2): 78-82.OstanekBFurlanDMavecTLukac-BajaloJUGT1A1(TA)n promoter polymorphism — A new case of a (TA)8 allele in CaucasiansBlood Cells Mol Dis200738278–8210.1016/j.bcmd.2006.10.16017196409Search in Google Scholar
Biondi ML, Turri O, Dilillo D, Stival G, Guagnellini E. Contribution of the TATA-box genotype (Gilbert syndrome) to serum bilirubin concentrations in the Italian population. Clin Chem. 1999; 45(6 Pt 1): 897-898.BiondiMLTurriODililloDStivalGGuagnelliniEContribution of the TATA-box genotype (Gilbert syndrome) to serum bilirubin concentrations in the Italian populationClin Chem1999456 Pt 1897–89810.1093/clinchem/45.6.897Search in Google Scholar
Etienne-Grimaldi MC, Boyer JC, Thomas F, Quaranta S, Picard N, Loriot MA, et al. UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice. Fundam Clin Pharmacol. 2015; 29(3): 219-237.Etienne-GrimaldiMCBoyerJCThomasFQuarantaSPicardNLoriotMAUGT1A1 genotype and irinotecan therapy: general review and implementation in routine practiceFundam Clin Pharmacol2015293219–23710.1111/fcp.1211725817555Search in Google Scholar
Gammal RS, Court MH, Haidar CE, Iwuchukwu OF, Gaur AH, Alvarellos M, et al.; CPIC. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir prescribing. Clin Pharmacol Ther. 2016; 99(4): 363-369.GammalRSCourtMHHaidarCEIwuchukwuOFGaurAHAlvarellosMCPICClinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir prescribingClin Pharmacol Ther2016994363–36910.1002/cpt.269478505126417955Search in Google Scholar
Culley CL, Kiang TK, Gilchrist SE, Ensom MH. Effect of the UGT1A1 28 allele on unconjugated hyperbilirubinemia in HIV-positive patients receiving Atazanavir: A systematic review. Ann Pharmacother. 2013; 47(4): 561-72.CulleyCLKiangTKGilchristSEEnsomMHEffect of the UGT1A1 28 allele on unconjugated hyperbilirubinemia in HIV-positive patients receiving Atazanavir: A systematic reviewAnn Pharmacother2013474561–7210.1345/aph.1R55023548653Search in Google Scholar
Fujita K, Sugiyama M, Akiyama Y, Ando Y, Sasaki Y. The small-molecule tyrosine kinase inhibitor nilotinib is a potent noncompetitive inhibitor of the SN-38 glucuronidation by human UGT1A1. Cancer Chemother Pharmacol. 2011; 67(1): 237-241.FujitaKSugiyamaMAkiyamaYAndoYSasakiYThe small-molecule tyrosine kinase inhibitor nilotinib is a potent noncompetitive inhibitor of the SN-38 glucuronidation by human UGT1A1Cancer Chemother Pharmacol2011671237–24110.1007/s00280-010-1445-320814789Search in Google Scholar
de Souza MM, Vaisberg VV, Abreu RM, Ferreira AS, da Silva Ferreira C, Nasser PD, et al. UGT1A1 28 relationship with abnormal total bilirubin levels in chronic hepatitis C patients: Outcomes from a case-control study. Medicine (Baltimore). 2017; 96(11): e6306.deSouza MMVaisbergVVAbreuRMFerreiraASdaSilva Ferreira CNasserPDUGT1A1 28 relationship with abnormal total bilirubin levels in chronic hepatitis C patients: Outcomes from a case-control studyMedicine (Baltimore)20179611e630610.1097/MD.0000000000006306536989428296739Search in Google Scholar
